TherapeuticsMD, Inc. (TXMD): Shareholders' Equity
$26.88M
As of 2025-12-31
$27.13M
As of 2026-06-30
-8.6%
3-year compound annual growth
-8.2%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $26.88M | -1.8% | 2026-04-01, Balance as of period end |
| 2024-12-31 | $27.37M | -6.5% | 2026-04-01, Balance as of period end |
| 2023-12-31 | $29.29M | -16.7% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $35.14M | n/m | 2024-03-29, Balance as of period end |
| 2021-12-31 | -$93.62M | n/m | 2023-04-07, Balance as of period end |
| 2020-12-31 | -$124.00M | n/m | 2022-03-23, Balance as of period end |
| 2019-12-31 | $9.20M | -90.6% | 2022-03-23, Balance as of period end |
| 2018-12-31 | $97.52M | -24.9% | 2021-03-04, Balance as of period end |
| 2017-12-31 | $129.91M | +1.9% | 2020-02-24, Balance as of period end |
| 2016-12-31 | $127.49M | +102.2% | 2019-02-27, Balance as of period end |
| 2015-12-31 | $63.06M | +30.3% | 2018-02-23, Balance as of period end |
| 2014-12-31 | $48.39M | -11.5% | 2017-02-28, Balance as of period end |
| 2013-12-31 | $54.70M | n/m | 2016-02-26, Balance as of period end |
| 2012-12-31 | -$1.43M | n/m | 2015-03-12, Balance as of period end |
| 2011-12-31 | -$1.71M | n/m | 2013-03-12, Balance as of period end |
| 2010-12-31 | $964.4K | n/a | 2012-03-27, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $26.88M | -1.8% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $7.40M | +23.1% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $339.77M | -27.7% |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | -$126.24M | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $47.70M | -24.5% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $16.80M | -9.5% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $3.83M | -24.2% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $18.22M | -53.5% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $22.74M | +193.5% |
Compare TXMD, XBIO, UPB, RNAC side by side · Screen every company in Pharmaceutical Preparations ↗